DrugPatentWatch Database Preview
Investigational Drug Information for BCT197
Email this page to a colleague
What is the drug development status for BCT197?
BCT197 is an investigational drug.
There have been 5 clinical trials for BCT197.
The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2016.
The most common disease conditions in clinical trials are Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive, and Lung Diseases. The leading clinical trial sponsors are Mereo BioPharma, Novartis Pharmaceuticals, and Novartis.
There are fourteen US patents protecting this investigational drug and two hundred and thirty international patents.
Summary for BCT197
| US Patents | 14 |
| International Patents | 230 |
| US Patent Applications | 65 |
| WIPO Patent Applications | 42 |
| Japanese Patent Applications | 16 |
| Clinical Trial Progress | Phase 2 (2016-08-01) |
| Vendors | 27 |
Recent Clinical Trials for BCT197
| Title | Sponsor | Phase |
|---|---|---|
| The Effect of Itraconazole on BCT197 Exposure in Healthy Male Participants | Mereo BioPharma | Phase 1 |
| The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers | Mereo BioPharma | Phase 1 |
| Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease | Mereo BioPharma | Phase 2 |
Clinical Trial Summary for BCT197
Top disease conditions for BCT197
Top clinical trial sponsors for BCT197
US Patents for BCT197
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| BCT197 | ⤷ Try it Free | JAK inhibitors containing a 4-membered heterocyclic amide | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | ⤷ Try it Free |
| BCT197 | ⤷ Try it Free | Fused imidazo-piperidine JAK inhibitors | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | ⤷ Try it Free |
| BCT197 | ⤷ Try it Free | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD | Fulcrum Therapeutics, Inc. (Cambridge, MA) | ⤷ Try it Free |
| BCT197 | ⤷ Try it Free | JAK inhibitors containing a 4-membered heterocyclic amide | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | ⤷ Try it Free |
| BCT197 | ⤷ Try it Free | Methods of treatment using a JAK inhibitor compound | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for BCT197
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| BCT197 | Argentina | AR111241 | 2037-03-09 | ⤷ Try it Free |
| BCT197 | Argentina | AR111242 | 2037-03-09 | ⤷ Try it Free |
| BCT197 | Australia | AU2018231032 | 2037-03-09 | ⤷ Try it Free |
| BCT197 | Australia | AU2018231035 | 2037-03-09 | ⤷ Try it Free |
| BCT197 | Brazil | BR112019018648 | 2037-03-09 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
